NCT00523731View on ClinicalTrials.gov

ACPs in Severe PAD/CLI by Direct Intramuscular Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

March 31, 2007

Conditions
Peripheral Arterial DiseaseCritical Limb Ischemia
Interventions
PROCEDURE

Angiogenic Cell Precursors (ACPs) or Vescell TM

Trial Locations (1)

74410

Dr. Valentin Fulga, Tel Viv

All Listed Sponsors
lead

TheraVitae Ltd.

INDUSTRY

NCT00523731 - ACPs in Severe PAD/CLI by Direct Intramuscular Injection | Biotech Hunter | Biotech Hunter